Hypermarcas Shares Outstanding 2012-2025 | HYPMY

Hypermarcas shares outstanding from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Hypermarcas Annual Shares Outstanding (Millions of Shares)
2024	638
2023	638
2022	639
2021	640
2020	638
2019	640
2018	639
2017	631
2016	631
2015	644
2014	629
2013
2012	671
2011	607

Hypermarcas Quarterly Shares Outstanding (Millions of Shares)
2025-09-30	633
2025-06-30	626
2025-03-31	639
2024-12-31	638
2024-09-30	628
2024-06-30	631
2024-03-31	627
2023-12-31	638
2023-09-30	638
2023-06-30	639
2023-03-31	639
2022-12-31	639
2022-09-30	639
2022-06-30	639
2022-03-31	636
2021-12-31	640
2021-09-30	643
2021-06-30	627
2021-03-31	636
2020-12-31	638
2020-09-30	636
2020-06-30	640
2020-03-31	640
2019-12-31	640
2019-09-30	636
2019-06-30	636
2019-03-31	630
2018-12-31	639
2018-09-30	640
2018-06-30	631
2018-03-31	638
2017-12-31	631
2017-09-30	633
2017-06-30	608
2017-03-31	642
2016-12-31	631
2016-09-30	632
2016-06-30	643
2016-03-31	644
2015-12-31	644
2015-09-30	628
2015-06-30	616
2015-03-31	648
2014-12-31	650
2014-09-30	632
2014-06-30	631
2014-03-31	616
2013-12-31
2013-09-30	617
2013-06-30	644
2013-03-31	626
2012-12-31	594
2012-09-30	622
2012-06-30	743
2012-03-31	510
2011-12-31
2011-09-30	635
2011-06-30
2011-03-31	165

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$2.658B	$1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$100.311B	35.03
Takeda Pharmaceutical (TAK)	Japan	$58.739B	11.54
Zoetis (ZTS)	United States	$53.462B	19.73
BeOne Medicines - (ONC)	Switzerland	$37.951B	201.20
Sandoz Group AG (SDZNY)	Switzerland	$37.721B	0.00
Otsuka Holdings, - (OTSKY)		$37.221B	0.00
Daiichi Sankyo, - (DSNKY)	Japan	$36.542B	0.00
United Therapeutics (UTHR)	United States	$20.394B	17.95
Shionogi (SGIOY)	Japan	$19.736B	15.26
Merck (MKKGY)	Germany	$19.561B	12.06
IPSEN (IPSEY)	France	$15.077B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.055B	0.00
Neurocrine Biosciences (NBIX)	United States	$12.457B	26.92
Summit Therapeutics (SMMT)	United States	$11.536B	0.00
Orion OYJ (ORINY)	Finland	$11.214B	19.47
Madrigal Pharmaceuticals (MDGL)	United States	$10.554B	0.00
Eisai (ESAIY)		$9.636B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$8.769B	20.98
Stevanato Group S.p.A (STVN)	Italy	$4.849B	27.14
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.828B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.659B	22.12
Crinetics Pharmaceuticals (CRNX)	United States	$4.363B	0.00
Indivior Pharmaceuticals (INDV)	United States	$4.323B	17.64
Corcept Therapeutics (CORT)	United States	$4.204B	45.42
NewAmsterdam Pharma (NAMS)	Netherlands	$3.927B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.322B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.990B	9.54
Dyne Therapeutics (DYN)	United States	$2.220B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.119B	40.81
Avadel Pharmaceuticals (AVDL)	Ireland	$2.113B	0.00
Soleno Therapeutics (SLNO)	United States	$2.000B	0.00
Ocular Therapeutix (OCUL)	United States	$1.933B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.876B	22.23
Harrow (HROW)	United States	$1.766B	108.39
Ardelyx (ARDX)	United States	$1.669B	0.00
Enliven Therapeutics (ELVN)	United States	$1.586B	0.00
Oruka Therapeutics (ORKA)	United States	$1.559B	0.00
Definium Therapeutics (DFTX)	United States	$1.552B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.551B	0.00
Relay Therapeutics (RLAY)	United States	$1.548B	0.00
Nektar Therapeutics (NKTR)	United States	$1.451B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.447B	7.17
BioCryst Pharmaceuticals (BCRX)	United States	$1.425B	84.50
Evotec AG (EVO)	Germany	$1.248B	0.00
Savara (SVRA)	United States	$1.139B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.132B	0.00
Theravance Biopharma (TBPH)	United States	$0.990B	41.55
Cronos Group (CRON)	Canada	$0.988B	0.00
Aktis Oncology (AKTS)	United States	$0.900B	0.00
ARS Pharmaceuticals (SPRY)	United States	$0.875B	0.00
Xencor (XNCR)	United States	$0.828B	0.00
Esperion Therapeutics (ESPR)	United States	$0.820B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.754B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.732B	17.31
Bioventus (BVS)	United States	$0.684B	14.02
Rigel Pharmaceuticals (RIGL)	United States	$0.623B	5.56
ProKidney (PROK)	United States	$0.596B	0.00
Lyell Immunopharma (LYEL)	United States	$0.549B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.534B	0.00
Altimmune (ALT)	United States	$0.511B	0.00
Siga Technologies (SIGA)	United States	$0.486B	6.66
Zevra Therapeutics (ZVRA)	United States	$0.479B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.474B	0.00
Organogenesis (ORGO)	United States	$0.473B	0.00
Nature's Sunshine Products (NATR)	United States	$0.471B	28.03
Lexeo Therapeutics (LXEO)	United States	$0.461B	0.00
Aquestive Therapeutics (AQST)	United States	$0.445B	0.00
USANA Health Sciences (USNA)	United States	$0.382B	10.66
Aclaris Therapeutics (ACRS)	United States	$0.346B	0.00
Protara Therapeutics (TARA)	United States	$0.336B	0.00
Akebia Therapeutics (AKBA)	United States	$0.321B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.318B	0.00
Cybin (HELP)	Canada	$0.304B	0.00
Relmada Therapeutics (RLMD)	United States	$0.273B	0.00
Minerva Neurosciences (NERV)	United States	$0.271B	0.00
Avalo Therapeutics (AVTX)	United States	$0.264B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.263B	0.00
Larimar Therapeutics (LRMR)	United States	$0.261B	0.00
Journey Medical (DERM)	United States	$0.257B	0.00
OmniAb (OABI)	United States	$0.245B	0.00
Profound Medical (PROF)	Canada	$0.240B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.224B	0.00
MediWound (MDWD)	Israel	$0.222B	0.00
Context Therapeutics (CNTX)	United States	$0.211B	0.00
Heron Therapeutics (HRTX)	United States	$0.211B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.210B	0.00
Surrozen (SRZN)	United States	$0.210B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.184B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Galectin Therapeutics (GALT)	United States	$0.178B	0.00
AleAnna (ANNA)	United States	$0.171B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.157B	0.00
Century Therapeutics (IPSC)	United States	$0.153B	0.00
Prelude Therapeutics (PRLD)	United States	$0.140B	0.00
VAXART, INC (VXRT)	United States	$0.136B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.133B	0.00
Avita Medical (RCEL)	United States	$0.127B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.116B	0.00
Korro Bio (KRRO)	United States	$0.105B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Incannex Healthcare (IXHL)	Australia	$0.093B	0.00
Vivani Medical (VANI)	United States	$0.092B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.091B	0.00
Champions Oncology (CSBR)	United States	$0.084B	35.76
Pyxis Oncology (PYXS)	United States	$0.081B	0.00
Assertio Holdings (ASRT)	United States	$0.079B	0.00
PolyPid (PYPD)	Israel	$0.070B	0.00
Gain Therapeutics (GANX)	United States	$0.070B	0.00
HST Global (HSTC)	United States	$0.069B	0.00
Rafael Holdings (RFL)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.059B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.058B	48.50
Fractyl Health (GUTS)	United States	$0.057B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.057B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.056B	0.00
Dominari Holdings (DOMH)	United States	$0.055B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.053B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.051B	0.00
Nutriband (NTRB)	United States	$0.050B	0.00
Lipocine (LPCN)	United States	$0.048B	0.00
ElectroCore (ECOR)	United States	$0.043B	0.00
Lite Strategy (LITS)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Plus Therapeutics (PSTV)	United States	$0.038B	0.00
Talphera (TLPH)	United States	$0.038B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
SCYNEXIS (SCYX)	United States	$0.031B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.030B	0.00
TherapeuticsMD (TXMD)	United States	$0.027B	0.00
Wellgistics Health (WGRX)	United States	$0.025B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.024B	0.00
Natural Alternatives (NAII)	United States	$0.022B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.018B	0.00
Scienture Holdings (SCNX)	United States	$0.018B	0.00
Klotho Neurosciences (KLTO)	United States	$0.016B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.016B	0.00
Traws Pharma (TRAW)	United States	$0.015B	0.02
Iterum Therapeutics (ITRM)	Ireland	$0.015B	0.00
Vyome Holdings (HIND)	United States	$0.015B	0.00
Cosmos Health (COSM)	United States	$0.014B	0.00
Vivos Therapeutics (VVOS)	United States	$0.014B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Liminatus Pharma (LIMN)	United States	$0.012B	0.00
Tempest Therapeutics (TPST)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.010B	0.00
Inotiv (NOTV)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Ainos (AIMD)	United States	$0.007B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Heatwurx (PCSA)	United States	$0.005B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.003B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.003B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.003B	0.00
Lyra Therapeutics (LYRA)	United States	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00